SCHEMBL16202074

SCHEMBL16202074

Cc1cn(-c2ccc(Cl)cc2)nc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.47
GPR55 Q9Y2T6 4/20 0.47
CNR2 P34972 3/20 0.47
GPR35 Q9HC97 1/20 0.47
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
KDM4E B2RXH2 3/20 0.44
POLB P06746 1/20 0.42
NOTUM Q6P988 4/20 0.41
F2 P00734 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ATM Q13315 1/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
KCNH2 Q12809 1/20 0.39
ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16202073 0.84 CNR1 (0.47) CNR1GPR55CNR2GPR35NPC1
SCHEMBL16202083 0.83 CNR1 (0.47) CNR1GPR55CNR2GPR35NPC1
SCHEMBL7095866 0.82 KDM4E (0.50) CNR1GPR55CNR2GPR35NPC1
SCHEMBL9930636 0.81 NPC1 (0.46) CNR1GPR55CNR2GPR35NPC1
SCHEMBL24185328 0.80 PTGS2 (0.44) CNR1GPR55CNR2NPC1RAB9A
SCHEMBL2611844 0.80 NPC1 (0.44) NPC1RAB9AKDM4EPOLBNOTUM
SCHEMBL16202077 0.79 NOTUM (0.48) NPC1RAB9ANOTUMGAAMAPT
SCHEMBL7859575 0.79 CNR1 (0.54) CNR1GPR55CNR2GPR35KDM4E
SCHEMBL5341410 0.79 RAB9A (0.50) CNR1GPR55CNR2NPC1RAB9A
Ammonia Solution, Strong SCHEMBL28029770 0.78 RAB9A (0.49) CNR1GPR55CNR2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160249615-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors BASF SE (DE) 2016-09-01 US disclosed
US-20160145219-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2016-05-26 US disclosed
US-20160145202-A1 Strobilurin Type Compounds for Combating Phytopathogenic Fungi BASF SE (DE) 2016-05-26 US disclosed
US-20160122327-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2016-05-05 US disclosed
US-9271501-B2 Use of strobilurin type compounds for combating phytopathogenic fungi resistant to QO inhibitors BASF SE (DE) 2016-03-01 US disclosed
US-20140323305-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors BASF SE (DE) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122327-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI SNX1, DPM1, SNU13 CNR1 2644/4885GPR55 3506/4885CNR2 4033/4885
US-20160145219-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI DPM1, CROCC, SNX1 CNR1 2619/4885GPR55 3573/4885CNR2 3667/4885
US-20160145202-A1 Strobilurin Type Compounds for Combating Phytopathogenic Fungi DPM1, CROCC, SNX1 CNR1 2619/4885GPR55 3573/4885CNR2 3667/4885
US-20140323305-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors SQOR, COX5B, UQCRB CNR1 2770/4885GPR55 3255/4885CNR2 3732/4885
US-20160249615-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors SQOR, COX5B, UQCRB CNR1 2770/4885GPR55 3255/4885CNR2 3732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.